NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/09/2025
Back to search
Official data from USPTO
KAZIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
09/10/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
09/26/2017
Registration date
12/04/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/09/2025
Last transaction
09/10/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Sydney, NSW, AU
Examiner
FLETCHER, TRACY
Current location
Historical data usage
Holders and representatives
Holders
Kazia Therapeutics Limited
Kazia Therapeutics Limited
Representatives
Sana Hakim K&L Gates LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in science; chemicals for use in the manufacture of pharmaceuticals and medicine; biochemicalsprecursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticals
Class 5
Pharmaceutical preparationscytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human usepharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposes
Class 42
Scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticalsscientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services
Publications
History of USPTO decisions and trademark events.
36 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
09/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2025
ES71
TEAS SECTION 71 RECEIVED
06/03/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/19/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/29/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/15/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/11/2019
FIMP
FINAL DISPOSITION PROCESSED
03/11/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/04/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/18/2018
PUBO
PUBLISHED FOR OPPOSITION
09/18/2018
GPNX
NOTIFICATION PROCESSED BY IB
09/15/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/29/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/29/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/29/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/16/2018
DMCC
DATA MODIFICATION COMPLETED
08/16/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/14/2018
ALIE
ASSIGNED TO LIE
08/14/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/14/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/14/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/14/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/06/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/06/2018
RFNT
REFUSAL PROCESSED BY IB
03/24/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/07/2018
RFRR
REFUSAL PROCESSED BY MPU
03/07/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/02/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/01/2018
CNRT
NON-FINAL ACTION WRITTEN
02/28/2018
DOCK
ASSIGNED TO EXAMINER
02/26/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/26/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/15/2018
Continuous trademark protection
Get notified about every new filing that threatens KAZIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.